DAY 01

September 18, 2021 - Saturday
Getting Up to Date with Guidelines
Time (IST) Scientific Program
HALL A
11:00 AM - 01:00 PM Session 1 Session Chair:
Alison Street
(Melbourne)
Introduction / Conference Opening
11:00 AM - 11:30 AM Current and Future challenges of Haemophilia Treatment Johannes Oldenburg
(Bonn)
11:30 AM - 12:00 PM WFH Guidelines for Haemophilia 2020: What Has Changed? Alok Srivastava
(Vellore)
12:00 PM - 12:30 PM WFH Guidelines for Haemophilia 2020: Implications for Management of Musculoskeletal Issues Adolfo Llinas
(Bogota)
12:30 PM - 01:00 PM Principles and Practice of Prophylaxis Nguyen Thi Mai
(Hanoi)
HALL A HALL B
01:00 PM - 01:45 PM Novo Nordisk Symposium
Role of EHL FIX in managing Haemophilia B: paradigm shift with nonacog beta pegol		 Takeda Symposium
Emerging role of EHL in Haemophilia A –
Optimizing patient outcome with personalized Prophylaxis
01:00 PM - 01:02 PM Welcome & Introduction Rohan Kolla
(Bangalore)		 01:00 PM - 01:07 PM Introduction & Context Setting Tulika Seth
(New Delhi)
01:02 PM - 01:12 PM EHL FIX – Guidelines and India Experience Aby Abraham
(Vellore)		 01:07 PM - 01:15 PM Emerging clinical evidence on FVIII EHL Shashikant Apte
(Pune)
01:12 PM - 01:35 PM Case Discussion:
Paradigm Change in Haemophilia 'B' management		 Johnny Mahlangu
(Johannesburg)		 01:15 PM - 01:20 PM Importance of personalization of prophylaxis & Home therapy Chandrakala S.
(Mumbai)
01:35 PM - 01:45 PM Discussion & Conclusion 01:20 PM - 01:45 PM Panel Discussion Tulika Seth (New Delhi),
Shashikant Apte (Pune),
R K Jena (Cuttack),
Chandrakala S (Mumbai),
Neeraj S (Cochin)
01:45 PM - 02:00 PM Lunch break
HALL A
(Clinical Topics)		 Session Chair/ Speakers HALL B
(MSK Workshop)
 Session Chair/ Speakers
02:00 PM - 03:00 PM Session 2 Session Chair:
Joyce Lam Ching Mei
(Singapore)		 Session 4
“Multidisciplinary approach to the assessment and management of Joint Complication in PWH”		 Session Chairs:
Judy Ann John
(Vellore),
Ratcharin Kongkasuwan
(Bangkok)
02:00 PM - 02:30 PM VWD Diagnosis and Management Guidelines: Key Messages for Clinical Practice Paula James
(Ontario)
02:30 PM - 03:00 PM VWD – Special Considerations in Adolescents and Women Jameela Sathar
(Ampang)		 02:00 PM - 02:15 PM Introduction Faculties (Vellore):

Merlyn Tilak,
Andriya Rajendran,
Ronald Thomvic Maradona J,
Sneha Sara Sabu,
Naveen Thomas Cherian,
Sandeep Albert
03:00 PM - 04:00 PM Session 3 Session Chair:
Tadashi Matsushita
(Nagoya)		 02:15 PM - 03:00 PM Case 1: Knee flexion deformity, Hemophilic arthropathy
03:00 PM - 03:10 PM Q&A
03:00 PM - 03:30 PM Advances in the management of Rare Bleeding Disorders Ampaiwan Chuansumrit
(Bangkok)		 03:00 PM - 03:10 PM Case 2: Synovitis
03:45 PM - 03:55 PM Q&A
03:30 PM - 04:00 PM Glanzmann Thrombasthenia: What’s new Fouzia.N.A
(Vellore)		 03:55 PM - 04:00 PM Conclusion & Feedback
04:00 PM - 04:45 PM Roche Symposium Takeda Symposium
04:00 PM - 04:35 PM Role of Emicizumab in Haemophilia management Nita Radhakrishna
(Noida)		 4:00 PM - 04:45 PM Let's inhibit inhibitors with Feiba M. Joseph John
(Ludhiana)
04:35 PM - 04:45 PM Q & A  

DAY 02

September 19, 2021 - Sunday
Focus on Asia-Pacific Regional Practice
Time (IST) HALL A
(Clinical Topics)		 Session Chair/ Speakers HALL B
(Laboratory Workshop)		 Session Chair/ Speakers
11:00 AM - 12:00 PM Session 5 Session Chair:
Shashikant Apte
(Pune)		 Session 7 Session Chairs:
Tien Sim Leng
(Singapore),
Sukesh C Nair
(Vellore)
11:00 AM - 11:20 AM Covid-19 and Bleeding disorders-WFH Guidelines Cedric Hermans
(Brussels)		 Are chromogenic assays necessary in present day management of Haemophilia. Wong Wan Hui
(Singapore)
11:20 AM - 11:30 AM Impact of the COVID19 Pandemic on Haemophilia Practice in Asia-Pacific – Singapore Experience Ng Heng Joo
(Singapore)
11:30 AM - 11:40 AM Impact of the COVID19 Pandemic on Haemophilia Practice in Asia-Pacific – Philippines Experience Marilou A. Abiera
(Quezon)
11:40 AM - 12:00 PM Discussion
Implementation of the new VWD guidelines in the AP region – roadblocks and alleys.
 Tulasi Geevar
(Vellore)
12:00 PM - 01:00 PM Session 6 Session Chair:
Darintr Sosothikul
(Bangkok)
12:00 PM - 12:20 PM Impact of standard and novel therapies on inhibitor management Erik Berntorp
(Lund)
12:20 PM - 12:30 PM Use of Emicizumab in patients with and without Inhibitors - The Singapore Experience Joyce Lam Ching Mei
(Singapore)		 The role of genetic testing in present day management of Haemophilia Tien Sim Leng
(Singapore)
12:30 PM - 12:40 PM Prophylactic use of Emicizumab in patients with Hemophilia A with & without inhibitors – Cambodia Experience Chean Sophal
(Phnom Penh)
12:40 PM - 01:00 PM Discussion
01:00 PM - 01:45 PM Grifols Symposium
Importance of FVIII/VWF natural complex in Haemophilia A		 Novo Nordisk APAC Symposium
Importance of home therapy and role of turoctocog alfa pegol in managing Haemophilia A
1:00 PM - 1:10 PM Need of VWF/FVIII natural complex Nishant Singh
(Gurugram)		 01:00 PM - 01:02 PM Welcome & Introduction Myriam Dardikh
(Dubai)
1:10 PM - 1:40 PM Emerging importance of VWF in Haemophilia 'A' Management M. Joseph John
(Ludhiana)		 01:02 PM - 01:12 PM Factor Level Matters For Your Patients / Home Treatment Zulaiha Muda
(Kuala Lumpur)
01:12 PM - 01:35 PM Safety and efficacy of turoctocog alfa pegol in clinical trial programme and real-world experience Kingsley Hampton
(Sheffield)
1:40 PM - 1:45 PM Q & A 01:35 PM - 01:45 PM Q & A / Conclusion
01:45 PM - 02:00 PM Lunch Break
02:00 PM - 03:30 PM Session 8 Session Chair:
Flerida Galsim - Hernandez
(Manila)
Basic Principles – Clot based, Factors, Bethesda, FXIII and VWD testing.
Wong Wan Hui
(Singapore)
02:00 PM - 02:30 PM WFH Global Survey 2020 - Analysis and Data Visualization from the AP Region, including data on Rare Bleeding Disorders. M. Joseph John
(Ludhiana)
02:30 PM - 03:00 PM Registries in the AP Region - Practical tips from the Australian Bleeding Disorders Registry Experience Simon McRae
(Tasmania)
03:00 PM - 03:30 PM Gene Therapy – Experience from China Renchi Yang
(Tianjin)		 Identifying errors in laboratory procedures by its own inherent characteristics before they impact coagulation test results.
Sukesh C Nair
(Vellore)
03:30 PM - 03:45 PM
Recap & Highlights
 Joyce Lam Ching Mei (Singapore), Alison Street (Melbourne), Judy Ann John (Vellore), Sukesh C Nair (Vellore)
03:50 PM - 04:00 PM Closing Remarks Alison Street (Melbourne), Renu Saxena (Gurugram)